AMSTERDAM, July 29 /EMWNews/ --



    - Database Now Offers Early Access to Research From 3000 Journals



    Scopus(R), the world's largest abstract and citation database of

peer-reviewed literature, today announced that it has added

"Articles-in-Press" (AiP), abstracts of accepted research papers published

prior to being printed, from journals produced by Karger Medical and

Scientific Publishers, and Nature Publishing Group (NPG). In the fall, AiPs

from BioMed Central and IEEE will also be available. Scopus

(http://www.info.scopus.com) previously offered access to AiPs from

Elsevier and Springer that included 2500 titles. This number will now rise

to approximately 3000.



    Scopus AiP abstracts are citable and precede the final published,

printed version by up-to-four months, significantly accelerating the

knowledge discovery process for researchers. Researchers will gain access

to the full-text by linking from Scopus to the publishers' digital library.

This early access provides greater connectivity to the current state of

research in a range of fields, as well as a more timely method for

evaluating the output of authors and institutions. Since AiPs are posted

online either as an accepted manuscript or online publication (according to

each publisher's release policy), they may still be subject to changes

and/or corrections by the author or publisher. Scopus clearly labels AiPs

as such so researchers are aware that an updated abstract will be made

available once the papers are in print.



    "Pre-print articles are extremely helpful in my work as a

practitioner," comments Mark Levy, Senior Clinical Research Fellow for the

Allergy & Respiratory Research Group at the University of Edinburgh. "I

need to be sure I have access to the latest research that is relevant to my

patients' needs and treatment plans."



    "Gaining access to the research pipeline can have an enormous impact,"

explains Niels Weertman, Director Scopus and Scirus. "It can open the door

for researchers to new ideas and collaboration partners, speeding the

advancement of science and in the medical community it can quite literally

be a matter of life and death."

    About Scopus



    Covering the world's research literature, Scopus is the largest

abstract and citation database of peer-reviewed literature and quality Web

sources with smart tools to track, analyze and visualize research. Scopus

was designed and developed with over 500 users and librarians

internationally. Its unique database contains abstracts and references from

over 15,000 peer-reviewed journals from 4,000 publishers worldwide,

ensuring broad interdisciplinary coverage. In addition, Scopus not only

offers users citation information about the articles covered, but also

directly integrates Web and patent searches. Direct links to full-text

articles, library resources and other applications like reference

management software, make Scopus quicker, easier and more comprehensive to

use than any other literature research tool. For more information about

Scopus please visit http://www.info.scopus.com.



    About Elsevier



    Elsevier is a world-leading publisher of scientific, technical and

medical information products and services. Working in partnership with the

global science and health communities, Elsevier's 7,000 employees in over

70 offices worldwide publish more than 2,000 journals and 1,900 new books

per year, in addition to offering a suite of innovative electronic

products, such as ScienceDirect (http://www.sciencedirect.com/), MD Consult

(http://www.mdconsult.com/), Scopus (http://www.info.scopus.com/),

bibliographic databases, and online reference works.



    Elsevier (http://www.elsevier.com/) is a global business headquartered

in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part

of Reed Elsevier Group plc (http://www.reedelsevier.com/), a world-leading

publisher and information provider. Operating in the science and medical,

legal, education and business-to-business sectors, Reed Elsevier provides

high-quality and flexible information solutions to users, with increasing

emphasis on the Internet as a means of delivery. Reed Elsevier's ticker

symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and

ENL (New York Stock Exchange).






    CONTACT:



    Malkie Bernheim

    Padilla Speer Beardsley

    +1-212-752-8338 ext. 662

    [email protected]